arrow
C

Catherine R. Marinac

Dana-Farber Cancer Institute
H指数:31
被引数:5,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Short-Term 24h Dietary Recalls from Observational Studies Cannot Support Claims on Mortality

短期24小时膳食回顾来自观察性研究无法支持死亡率方面的声明

2025-11-060
PRE
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors

SWIFT-seq技术实现了对多发性骨髓瘤及其前体细胞中循环肿瘤细胞的全面单细胞转录组分析。

2025-08-080
PRE
Landscape Assessment of the Perceptions of Distress and Symptom Burden in Patients with Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM)

患者对不明原因单克隆丙种球蛋白病(MGUS)和冒烟型多发性骨髓瘤(SMM)相关痛苦与症状负担感知的景观评估

BLOOD
IF23.1
2024-11-050
PRE
Deep Learning Unveils Characteristics of Immune B Cell Aging in >17,000 Samples and Identifies Changes in the Immunoglobulin Repertoire Distribution and the Development of Monoclonal Gammopathy

深度学习揭示超过17,000个样本中免疫B细胞衰老的特征,并识别了免疫球蛋白谱系分布和单克隆丙种球蛋白病发展的变化

BLOOD
IF23.1
2024-11-050
PRE
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

关于多发性骨髓瘤先兆临床试验优化设计的圆桌讨论

2024-05-012
OA
Altered immune response to vaccination in patients with plasma cell premalignancy
2023-04-040
PRE
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

具有不确定意义的单克隆丙种球蛋白病或闷烧性多发性骨髓瘤 (PANGEA) 患者的个性化进展预测: 一项回顾性,多职业研究

2023-03-0119
OAAI